Status:
UNKNOWN
A Questionnaire for Endoscopic Prediction Improvement of Gastrointestinal Cancer
Lead Sponsor:
Yanqing Li
Conditions:
Early Detection of Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Despite improvements in a range of chemo, radio and surgical therapies, the overall survival at 5 years from gastrointestinal cancer remains poor. Endoscopic early diagnosis is a key strategy to impro...
Eligibility Criteria
Inclusion
- Patients aged more than 18 years with or without GI symptoms attending for endoscopy.
Exclusion
- Patients unable to cooperated the endoscopy or unable to complete it. People with endoscopy contraindications are naturally excluded.
Key Trial Info
Start Date :
May 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
34906 Patients enrolled
Trial Details
Trial ID
NCT04071431
Start Date
May 29 2019
End Date
April 1 2021
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China, 250012